Rinri Therapeutics Email Format
Biotechnology ResearchEngland, United Kingdom11-50 Employees
Rinri Therapeutics Ltd. is a private biotechnology company based in Sheffield, England, focused on regenerative cell therapies to treat sensorineural hearing loss. It aims to restore hearing by regenerating damaged sensory cells in the cochlea, addressing a global burden of SNHL where disease-modifying options are currently unavailable. The company operates within biotechnology research, pursuing first-in-class approaches rather than incremental improvements. It serves patients worldwide affected by sensorineural hearing loss, a population with limited therapeutic options beyond supportive care. Positioned in regenerative medicine within the biotech sector, Rinri seeks to reverse cellular damage in the inner ear rather than merely address symptoms. The firm has a relatively small team and participates in major industry events, reflecting active engagement in the broader life sciences community, such as appearances at the JP Morgan Healthcare Conference in 2025 and the Life Sciences Innovation Summit in 2025.